Article
Medrio, Inc. and PHASTAR announced that they have partnered aiming to leverage metadata surrounding electronic patient-reported outcomes (ePRO) for advanced data visualization, providing insight into patient compliance and burden.
PHASTAR ran a pilot with 33 volunteers completing EQ-5D, a health-related measure of quality-of-life questionnaire, to understand how metadata may be used effectively to monitor ePRO data collection during a study.
The PHASTAR team used Medrio ePRO for initial data collection and Medrio’s Export API to funnel the ePRO and metadata into PHASTAR’s data visualization tool, PHIZUAL.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.